Showing 961 - 980 results of 82,515 for search '(( 50 ((mean decrease) OR (((a decrease) OR (nn decrease)))) ) OR ( a d decrease ))', query time: 1.27s Refine Results
  1. 961

    Hematoxylin and eosin (H&E) and picrosirius red staining of LV-shRNA-ADAMTS-1 transduced vessels have increased lumen vessel area with decreased collagen expression. by Evelyn C. Nieves Torres (551495)

    Published 2014
    “…<b>A</b>) <b>Lower panel</b> is representative polarized light microscopy of picrosirius red-stained venous stenosis showing decreased fibrosis (collagen fibers are bright yellow) of the <b>LV</b> and <b>C</b> transduced vessels. …”
  2. 962
  3. 963
  4. 964
  5. 965

    Plasma membrane localized KCa3.1 is decreased by DN Rab1 and Rab8, but not by Rab2 or Rab6. by Claudia A. Bertuccio (309866)

    Published 2014
    “…<p>HEK293 cells were co-transfected with BLAP-KCa3.1 and either WT, DA or DN Rabs 1, 2, 6 or 8 and plasma membrane localized KCa3.1 evaluated by specific biotinylation, streptavidin labeling and IB (see Methods). As shown in <b>A</b> and <b>C</b>, DN Rab8 (T22N) and two different DN Rab1s (N124I, S25N) decreased expression of plasma membrane KCa3.1. …”
  6. 966

    BT9 reduces DAOY and D425 medulloblastoma cell invasion. by Zahra Motahari (6814013)

    Published 2024
    “…(C) Compared to control, BT9 treatment significantly decreased the number of invading DAOY and D425 cells (****p < 0.0001, BT9 vs vehicle control, n = 6). 4x magnification.…”
  7. 967
  8. 968
  9. 969
  10. 970
  11. 971
  12. 972
  13. 973
  14. 974
  15. 975
  16. 976

    IgG-mediated systemic anaphylaxis decreased in BasoDTR mice. by Kunie Matsuoka (400418)

    Published 2013
    “…<p>(A) BasoDTR mice (n = 4 per group) were treated once i.p. with 25 or 50 µg/kg of DT or PBS at 4 days prior to and were i.v. injected with 500 µg rat anti-FcγRII/III (2.4G2) antibodies in 200 µl PBS. …”
  17. 977
  18. 978
  19. 979

    Brivanib decreases viability of PDGF-BB treated LX-2 cells. by Ikuo Nakamura (548298)

    Published 2014
    “…Cells showed a brivanib dose-dependent decrease in viability, with half maximal inhibitory concentration (IC<sub>50</sub>) of 16.98 µM (95% CI 13.95 µM–20.67 µM). …”
  20. 980